. "Appendix: Agendas for Information-Gathering Meetings." Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report. Washington, DC: The National Academies Press, 2003.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Accelerating the Research, Development, and Acquisition of Medical Countermeasures Against Biological Warfare Agents: Interim Report
3:30
CBER Perspective on Opportunities for Accelerating Licensure of Medical Counter-measures for Biowarfare Agents
Kathryn Zoon, Ph.D., Director, Center for Biologics Evaluation and Research, Food and Drug Administration
Discussion
4:15
CDER Perspective on Opportunities for Accelerating Licensure of Medical Countermeasures for Biowarfare Agents
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research, Food and Drug Administration
Discussion
5:00
Adjourn
Tuesday, December 17, 2002
8:00 a.m.
Breakfast
8:30
Protecting Our Forces: Improving Vaccine Acquisition and Availability in the U.S. Military
IOM Report, September 2002
Stanley Lemon, M.D., Chair, IOM Committee on a Strategy for Minimizing the Impact of Naturally Occurring Infectious Diseases of Military Importance: Vaccine Issues in the U.S. Military
Discussion
9:15
DoD Acquisition of Vaccine Production
Report to the Deputy Secretary of Defense, December 2000
Gerald V.Quinnan, Jr., M.D., Professor and Chair of Preventive Medicine, Uniformed Services University of the Health Sciences
